Skip to main navigation Skip to search Skip to main content

COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 in Ghana, June 2022 to March 2024

  • Nicholas Amoako
  • , Sandra Cohuet
  • , Michael Rockson Adjei
  • , Celine Gurry
  • , Abraham Oduro
  • , Prince Darko Agyapong
  • , Osei Musah
  • , Ivy Asantewaa Asante
  • , Anthony Afum Adjei Awuah
  • , Reuben Ayivor-Djanie
  • , Kwabena Obeng Duedu
  • , Ernest Kenu
  • , George Obeng Adjei
  • , Ellis Owusu-Dabo
  • , John Amuasi
  • , Franklin Asiedu-Bekoe
  • , Dennis Laryea
  • , Francis Kasolo
  • , Sally Ann Ohene
  • , Angela M.C. Rose
    • Anthony Nardone, Worwui Kwame Archibald, James Humphreys, William Ampofo, Seth Owusu-Agyei, Jason Mathiu Mwenda, Kwaku Poku Asante
  • Kintampo Health Research Centre
  • World Health Organization
  • Ghana Health Service
  • University of Ghana
  • Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR)
  • Kwame Nkrumah University of Science and Technology
  • University of Health and Allied Sciences
  • Birmingham City University
  • WHO Regional Office for Africa
  • Sefako Makgatho University
  • Institute of Primate Research

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 in Ghana, June 2022 to March 2024'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science